
28/04/2025
"The UK has been a leader in funding and conducting research and development targeted at neglected diseases over the last two decades. Along with saving countless lives within some of the world’s poorest communities, that investment has had real health and economic benefits in the UK."
Following the publication of our report with Impact Global Health into the staggering health and economic benefits of investment into neglected disease R&D, Professors David Lalloo and Liam Smeeth from the London School of Hygiene & Tropical Medicine and Malaria No More CEO Astrid Bonfield have written for the Daily Telegraph on the need for the UK to continue to demonstrate global leadership.
Britain has an ethical responsibility to lead on R&D – but there are widespread benefits for the country too